Global Monoclonal antibodies (mAbs) Biosimilars Market 2020 by Company, Type and Application, Forecast to 2025

Report ID: 51413 | Publish Date: May, 2020 | Pages: 156 | Format : PDF

Market Overview

The global Monoclonal antibodies (mAbs) Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Monoclonal antibodies (mAbs) Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Monoclonal antibodies (mAbs) Biosimilars market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Monoclonal antibodies (mAbs) Biosimilars market has been segmented into Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb), Insulin, Interferon (IFN), Others, etc.

Breakdown by Application, Monoclonal antibodies (mAbs) Biosimilars has been segmented into Anti-Cancer, Anti-Inflammatory/Autoimmune, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Monoclonal antibodies (mAbs) Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Monoclonal antibodies (mAbs) Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Monoclonal antibodies (mAbs) Biosimilars market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Monoclonal antibodies (mAbs) Biosimilars Market Share Analysis

Monoclonal antibodies (mAbs) Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Monoclonal antibodies (mAbs) Biosimilars revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Monoclonal antibodies (mAbs) Biosimilars revenue and market share for each player covered in this report.

The major players covered in Monoclonal antibodies (mAbs) Biosimilars are: Biocon, Allergan, Hospira, Celltrion, AET Biotech, Dr. Reddy's Laboratories, Others, Accord Healthcare, 3SBio, Amega Biotech, etc. Among other players domestic and global, Monoclonal antibodies (mAbs) Biosimilars market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Biocon

Allergan

Hospira

Celltrion

AET Biotech

Dr. Reddy's Laboratories

Others

Accord Healthcare

3SBio

Amega Biotech

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Erythropoietin (EPO)

Human Growth Hormone (HGH)

Granulocyte- Colony Stimulating Factor (G-CSF)

Monoclonal Antibody (mAb)

Insulin

Interferon (IFN)

Others

Market segment by Application, can be divided into

Anti-Cancer

Anti-Inflammatory/Autoimmune


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Monoclonal antibodies (mAbs) Biosimilars

1.2 Classification of Monoclonal antibodies (mAbs) Biosimilars by Type

1.2.1 Overview: Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type in 2019

1.2.3 Erythropoietin (EPO)

1.2.4 Human Growth Hormone (HGH)

1.2.5 Granulocyte- Colony Stimulating Factor (G-CSF)

1.2.6 Monoclonal Antibody (mAb)

1.2.7 Insulin

1.2.8 Interferon (IFN)

1.2.9 Others

1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market by Application

1.3.1 Overview: Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Anti-Cancer

1.3.3 Anti-Inflammatory/Autoimmune

1.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

1.5 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2015-2020)

1.7 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2015-2025)

1.7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2015-2025)

1.7.3 Asia Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2015-2025)

1.7.4 South America Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2015-2025)

2 Company Profiles

2.1 Biocon

2.1.1 Biocon Details

2.1.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Biocon SWOT Analysis

2.1.4 Biocon Product and Services

2.1.5 Biocon Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.2 Allergan

2.2.1 Allergan Details

2.2.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Allergan SWOT Analysis

2.2.4 Allergan Product and Services

2.2.5 Allergan Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.3 Hospira

2.3.1 Hospira Details

2.3.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Hospira SWOT Analysis

2.3.4 Hospira Product and Services

2.3.5 Hospira Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.4 Celltrion

2.4.1 Celltrion Details

2.4.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Celltrion SWOT Analysis

2.4.4 Celltrion Product and Services

2.4.5 Celltrion Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.5 AET Biotech

2.5.1 AET Biotech Details

2.5.2 AET Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 AET Biotech SWOT Analysis

2.5.4 AET Biotech Product and Services

2.5.5 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.6 Dr. Reddy's Laboratories

2.6.1 Dr. Reddy's Laboratories Details

2.6.2 Dr. Reddy's Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Dr. Reddy's Laboratories SWOT Analysis

2.6.4 Dr. Reddy's Laboratories Product and Services

2.6.5 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.7 Others

2.7.1 Others Details

2.7.2 Others Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Others SWOT Analysis

2.7.4 Others Product and Services

2.7.5 Others Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.8 Accord Healthcare

2.8.1 Accord Healthcare Details

2.8.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Accord Healthcare SWOT Analysis

2.8.4 Accord Healthcare Product and Services

2.8.5 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.9 3SBio

2.9.1 3SBio Details

2.9.2 3SBio Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 3SBio SWOT Analysis

2.9.4 3SBio Product and Services

2.9.5 3SBio Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

2.10 Amega Biotech

2.10.1 Amega Biotech Details

2.10.2 Amega Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Amega Biotech SWOT Analysis

2.10.4 Amega Biotech Product and Services

2.10.5 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Players (2015-2020)

3.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Monoclonal antibodies (mAbs) Biosimilars Players Market Share

3.3.2 Top 10 Monoclonal antibodies (mAbs) Biosimilars Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Countries (2015-2020)

4.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Countries (2015-2026)

4.3 United States Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

4.4 Canada Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

4.5 Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Countries (2015-2020)

5.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Countries (2015-2026)

5.3 Germany Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

5.4 France Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

5.5 UK Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

5.6 Russia Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

5.7 Italy Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2015-2020)

6.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Regions (2015-2026)

6.3 China Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

6.4 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

6.5 Korea Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

6.6 India Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

6.7 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Monoclonal antibodies (mAbs) Biosimilars Market Size by Countries (2015-2020)

7.2 South America Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

7.4 Argentina Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions (2015-2020)

8.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

8.4 UAE Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

8.5 Egypt Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

8.6 South Africa Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Type (2015-2025)

9.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)

9.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Forecast by Type (2020-2025)

9.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Type (2015-2025)

9.2.1 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2015-2020)

9.2.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Application (2015-2025)

10.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)

10.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Forecast by Application (2020-2025)

10.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size and Forecast by Application (2015-2025)

10.2.1 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2015-2020)

10.2.2 Japan Monoclonal antibodies (mAbs) Biosimilars Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Monoclonal antibodies (mAbs) Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Regions (2015-2020)

Table 7. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions (2020-2025)

Table 9. Biocon Corporate Information, Location and Competitors

Table 10. Biocon Major Business

Table 11. Biocon Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 12. Biocon SWOT Analysis

Table 13. Biocon Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 14. Biocon Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. Allergan Corporate Information, Location and Competitors

Table 16. Allergan Major Business

Table 17. Allergan Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2018-2019)

Table 18. Allergan SWOT Analysis

Table 19. Allergan Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 20. Allergan Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. Hospira Corporate Information, Location and Competitors

Table 22. Hospira Major Business

Table 23. Hospira Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 24. Hospira SWOT Analysis

Table 25. Hospira Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 26. Hospira Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. Celltrion Corporate Information, Location and Competitors

Table 28. Celltrion Major Business

Table 29. Celltrion Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 30. Celltrion SWOT Analysis

Table 31. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 32. Celltrion Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. AET Biotech Corporate Information, Location and Competitors

Table 34. AET Biotech Major Business

Table 35. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 36. AET Biotech SWOT Analysis

Table 37. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 38. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. Dr. Reddy's Laboratories Corporate Information, Location and Competitors

Table 40. Dr. Reddy's Laboratories Major Business

Table 41. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 42. Dr. Reddy's Laboratories SWOT Analysis

Table 43. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 44. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Others Corporate Information, Location and Competitors

Table 46. Others Major Business

Table 47. Others Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 48. Others SWOT Analysis

Table 49. Others Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 50. Others Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. Accord Healthcare Corporate Information, Location and Competitors

Table 52. Accord Healthcare Major Business

Table 53. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 54. Accord Healthcare SWOT Analysis

Table 55. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 56. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. 3SBio Corporate Information, Location and Competitors

Table 58. 3SBio Major Business

Table 59. 3SBio Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 60. 3SBio SWOT Analysis

Table 61. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 62. 3SBio Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 63. Amega Biotech Corporate Information, Location and Competitors

Table 64. Amega Biotech Major Business

Table 65. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Total Revenue (USD Million) (2017-2018)

Table 66. Amega Biotech SWOT Analysis

Table 67. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product and Solutions

Table 68. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 69. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Players (2015-2020)

Table 70. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Players (2015-2020)

Table 71. Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) in Japan (2015-2020)

Table 72. Key Players Monoclonal antibodies (mAbs) Biosimilars Revenue Share in Japan (2015-2020)

Table 73. North America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2015-2020)

Table 74. North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2015-2020)

Table 75. North America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2020-2026)

Table 76. North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2020-2026)

Table 77. Europe Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2015-2020)

Table 78. Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2015-2020)

Table 79. Europe Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2020-2026)

Table 80. Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2020-2026)

Table 81. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2015-2020)

Table 82. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2015-2020)

Table 83. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2020-2026)

Table 84. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2020-2026)

Table 85. South America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2015-2020)

Table 86. South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2015-2020)

Table 87. South America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2020-2026)

Table 88. South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2020-2026)

Table 89. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2015-2020)

Table 90. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2015-2020)

Table 91. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Countries (2020-2026)

Table 92. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2020-2026)

Table 93. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Type (2015-2020)

Table 94. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2015-2020)

Table 95. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Forecast by Type (2020-2025)

Table 96. Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Type (2020-2025)

Table 97. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Type (2015-2020)

Table 98. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2015-2020)

Table 99. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Forecast by Type (2020-2025)

Table 100. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Type (2020-2025)

Table 101. Global Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Application (2015-2020)

Table 102. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2015-2020)

Table 103. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Forecast by Application (2020-2025)

Table 104. Global Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Application (2020-2025)

Table 105. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) by Application (2015-2020)

Table 106. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2015-2020)

Table 107. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Forecast by Application (2020-2025)

Table 108. Japan Monoclonal antibodies (mAbs) Biosimilars Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Monoclonal antibodies (mAbs) Biosimilars Picture

Figure 2. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type in 2019

Figure 4. Erythropoietin (EPO) Picture

Figure 5. Human Growth Hormone (HGH) Picture

Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Picture

Figure 7. Monoclonal Antibody (mAb) Picture

Figure 8. Insulin Picture

Figure 9. Interferon (IFN) Picture

Figure 10. Others Picture

Figure 11. Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application in 2019

Figure 12. Anti-Cancer Picture

Figure 13. Anti-Inflammatory/Autoimmune Picture

Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate (2015-2025) (USD Million)

Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Regions (2015-2025)

Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Regions in 2019

Figure 17. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions (2020-2025)

Figure 18. North America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)

Figure 19. Europe Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)

Figure 20. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)

Figure 21. South America Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)

Figure 22. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Revenue (USD Million) and Growth Rate (2015-2025)

Figure 23. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Players in 2019

Figure 24. Global Top 5 Players Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share in 2019

Figure 25. Top 10 Players Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share in Global Market in 2019

Figure 26. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) by Type (2015-2025)

Figure 27. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2015-2025)

Figure 28. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries (2015-2025)

Figure 29. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries in 2019

Figure 30. United States Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 31. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 32. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 33. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries (2015-2025)

Figure 34. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries in 2019

Figure 35. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 36. France Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 37. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 38. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 39. Spain Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 40. UK Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 41. Asia Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries (2015-2025)

Figure 42. Asia Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries in 2019

Figure 43. China Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 44. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 45. Korea Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 46. India Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 47. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 48. South America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries (2015-2025)

Figure 49. South America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries in 2019

Figure 50. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 51. Argentina Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 52. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries (2015-2025)

Figure 53. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Countries in 2019

Figure 54. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 55. UAE Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 56. Egypt Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 57. South Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (USD Million) and Forecast (2015-2025)

Figure 58. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2015-2020)

Figure 59. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2015-2020)

Figure 60. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2015-2020)

Figure 61. Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2015-2020)

Our Clients